| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
12.07.2012 US 201261671044 P
|
| (43) |
Date of publication of application: |
|
20.05.2015 Bulletin 2015/21 |
| (60) |
Divisional application: |
|
21170063.8 / 3919060 |
| (73) |
Proprietor: Emalex Biosciences, Inc. |
|
Chicago, IL 60611 (US) |
|
| (72) |
Inventors: |
|
- CHIPKIN, Richard, E.
Bethesda, MD 20814 (US)
- KWAN, Rudolf
Summit, NJ 07901 (US)
|
| (74) |
Representative: Witte, Weller & Partner Patentanwälte mbB |
|
Postfach 10 54 62
70047 Stuttgart
70047 Stuttgart (DE) |
| (56) |
References cited: :
WO-A1-96/13257
WO-A1-2012/033874
|
WO-A1-2011/057199
|
|
| |
|
|
- ANDREW C MCCREARY ET AL: "The thyrotrophin-releasing hormone analogue MK771 induces
tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists", EUROPEAN
JOURNAL OF PHARMACOLOGY, vol. 369, no. 1, 1 March 1999 (1999-03-01) , pages 1-9, XP055221494,
NL ISSN: 0014-2999, DOI: 10.1016/S0014-2999(99)00039-4
- DURSUN S M ET AL: "SIMILARITIES IN THE PHARMACOLOGY OF SPONTANEOUS AND DOI-INDUCED
HEAD-SHAKES SUGGEST 5HT2A RECEPTORS ARE ACTIVE UNDER PHYSIOLOGICAL CONDITIONS", PSYCHOPHARMACOLOGY,
SPRINGER VERLAG, BERLIN, DE, vol. 128, no. 2, 1 January 1996 (1996-01-01), pages 198-205,
XP001059606, ISSN: 0033-3158, DOI: 10.1007/S002130050125
- QIANG L ET AL: "Discovery of new SCH 39166 analogs as potent and selective dopamine
D1 receptor antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM,
NL, vol. 20, no. 3, 1 February 2010 (2010-02-01), pages 836-840, XP026861816, ISSN:
0960-894X [retrieved on 2010-01-04]
- ROGER KURLAN, M.D.: 'Tourette's Syndrome.' THE NEW ENGLAND JOURNAL OF MEDICINE vol.
363, 2010, pages 2332 - 2338, XP008176095 Retrieved from the Internet: <URL:http:JJwww.nejm.org/doi/full/
10.1056lnejmcp 1007805>
- DATABASE PUBMED [Online] 25 October 2006 XP055184772 Retrieved from NCBI Database
accession no. 10591286 & ROMACH MK ET AL.: 'Attenuation of the euphoric effects of
cocaine by the dopamine DI/D5 antagonist ecopipam (SCH 39166).' ARCH GEN PSYCHIATRY
vol. 56, no. 12, 1999, pages 1101 - 1106
- Lynn Dunlap: "TSA, Psyadon to collaborate on drug trial", , May 2011 (2011-05), Retrieved
from the Internet: URL:https://missouritsa.org/2011/05/12/tsa -psyadon-to-collaborate-on-drug-trial/
[retrieved on 2017-04-11]
- Jang-Woo Shin ET AL: "Interpretation of Animal Dose and Human Equivalent Dose for
Drug Development", The Journal of Korean Oriental Medicine, 1 May 2010 (2010-05-01),
pages 1-7, XP55315075, Retrieved from the Internet: URL:http://jkom.org/upload/31-3
01 [01-07].pdf [retrieved on 2016-10-31]
- REAGAN-SHAW SHANNON ET AL: "Dose translation from animal to human studies revisited.",
FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL
BIOLOGY MAR 2008, vol. 22, no. 3, March 2008 (2008-03), pages 659-661, ISSN: 1530-6860
- Anonymous: "Clinica Trials Archive - History of Changes for Study: NCT01244633", ,
8 May 2012 (2012-05-08), XP55738348, Retrieved from the Internet: URL:https://www.clinicaltrials.gov/ct2/his
tory/NCT01244633?V_5=View#StudyPageTop [retrieved on 2020-10-09]
- ARNE ASTRUP ET AL: "'Randomized Controlled Trials of the D1/D5 Antagonist Ecopipam
for Weight Loss in Obese Subjects", OBESITY RESEARCH, BATON ROUGE, LA, US, vol. 15,
no. 7, 7 July 2007 (2007-07-07), pages 1717-1731, XP008156118, ISSN: 1071-7323, DOI:
10.1002/HBM.22021
|
|
